A whole-animal phenotypic drug screen identifies suppressors of atherogenic lipoproteins
Daniel J. Kelpsch, Liyun Zhang, James H. Thierer…·Steven Arthur Farber
A zebrafish phenotypic drug screen identifies 49 ApoB-lowering compounds, with enoxolone showing efficacy dependent on HNF4 function, validating the LipoGlo platform for B-lp modulation.